Moneycontrol PRO
you are here: HomeNewsTrendsHealth

100 crore Covid vaccines administered: Survey finds 61% Indian citizens willing to take third dose

About 27 percent of respondents in a LocalCircles Survey said they would want a third dose only if COVID-19 is or likely to become prevalent at the time of availability of the third dose.

One Billion Vaccine doses, 100-crore vaccine dose, third dose, COVID-19 / October 21, 2021 / 12:30 PM IST
Source: AP

Source: AP

As India achieved the 100 crore COVID-19 vaccine doses milestone, at least 61 percent of citizens have expressed willingness to take the third dose of COVID-19 vaccine, if available, in the next six months, a survey has found.

Another 27 percent of respondents said they would want a third dose only if COVID-19 is or is likely to become prevalent at the time of availability of the third dose. Only six percent of citizens said they do not want to take the third dose, according to the findings of the survey by LocalCircles.

READ:Government to mark big billion jabs milestone with India's largest khadi tricolour, illumination, song

The survey received 9,245 responses from citizens residing in 301 districts of India. While 68 percent of respondents were men 32 percent were women. Around 43 percent of respondents were from tier 1 cities,29 percent from tier 2 and 28 percent from tier 3, 4 and rural districts.

The survey aimed to gauge citizens' willingness towards taking the third dose of the COVID-19 vaccine once it is made available in the next six months.


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

“This indicates that at this point majority of the population is willing to take the third dose to stay protected from COVID-19. While 61 per cent will take the third dose regardless, 27 per cent will take it if COVID-19 cases were to become prevalent again. This leaves only 12 per cent of citizens either qualifying as hesitant for the third dose or undecided at this point,” the survey said.

Follow all LIVE updates on the 100 Crore Vaccination milestone Here

India crossed the 100-crore vaccine dose mark on October 21, a milestone in its fight against coronavirus, overcoming logistic challenges and hesitancy as healthcare workers climbed mountains, crossed rivers and walked deserts to jab adult Indians against the dreaded virus.

It took India nine months to administer 100 crore jabs, with 74 percent of the adult population getting the first dose. More than 31 percent are fully vaccinated

The vaccine hesitancy study released by LocalCircles earlier this month indicated that only seven crore of the 94 crore Indian adults were hesitant. With 70 crore Indians already having taken the first dose, this means that over the next few months another 17 crore adults will hopefully take their first dose.

“People also believe that all activities of the economy being unlocked and schools working with full attendance are likely to lead rise in COVID-19 cases and hence the third dose once it becomes available will help them in staying protected from COVID-19,” it said.
Moneycontrol Contributor
first published: Oct 21, 2021 12:16 pm

stay updated

Get Daily News on your Browser
ISO 27001 - BSI Assurance Mark